AUPN627595A0 - Diagnostics and treatments of periodontal disease - Google Patents

Diagnostics and treatments of periodontal disease

Info

Publication number
AUPN627595A0
AUPN627595A0 AUPN6275A AUPN627595A AUPN627595A0 AU PN627595 A0 AUPN627595 A0 AU PN627595A0 AU PN6275 A AUPN6275 A AU PN6275A AU PN627595 A AUPN627595 A AU PN627595A AU PN627595 A0 AUPN627595 A0 AU PN627595A0
Authority
AU
Australia
Prior art keywords
complex
periodontal disease
prtr
prtk
multimeric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN6275A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Victorian Dairy Industry Authority
University of Melbourne
Original Assignee
VICTORIAN DAIRY IND
Victorian Dairy Industry Authority
University of Melbourne
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by VICTORIAN DAIRY IND, Victorian Dairy Industry Authority, University of Melbourne filed Critical VICTORIAN DAIRY IND
Priority to AUPN6275A priority Critical patent/AUPN627595A0/en
Publication of AUPN627595A0 publication Critical patent/AUPN627595A0/en
Priority to EP96934198A priority patent/EP0858504B1/en
Priority to US09/066,330 priority patent/US6511666B1/en
Priority to ZA969130A priority patent/ZA969130B/xx
Priority to NZ320015A priority patent/NZ320015A/xx
Priority to ES96934198T priority patent/ES2255082T3/es
Priority to DK96934198T priority patent/DK0858504T3/da
Priority to KR1019980703117A priority patent/KR100286055B1/ko
Priority to JP51691597A priority patent/JP4117026B2/ja
Priority to AT96934198T priority patent/ATE312909T1/de
Priority to AU72673/96A priority patent/AU715456B2/en
Priority to CA2235224A priority patent/CA2235224C/en
Priority to DE69635582T priority patent/DE69635582T2/de
Priority to PCT/AU1996/000673 priority patent/WO1997016542A1/en
Priority to US11/654,512 priority patent/US20070189982A1/en
Priority to US13/064,286 priority patent/US20110213129A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6427—Chymotrypsins (3.4.21.1; 3.4.21.2); Trypsin (3.4.21.4)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56955—Bacteria involved in periodontal diseases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
AUPN6275A 1995-10-30 1995-10-30 Diagnostics and treatments of periodontal disease Abandoned AUPN627595A0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
AUPN6275A AUPN627595A0 (en) 1995-10-30 1995-10-30 Diagnostics and treatments of periodontal disease
PCT/AU1996/000673 WO1997016542A1 (en) 1995-10-30 1996-10-30 Diagnostics and treatments of periodontal disease
DK96934198T DK0858504T3 (da) 1995-10-30 1996-10-30 Diagnostiske midler mod og behandlinger af periodontale sygdomme
JP51691597A JP4117026B2 (ja) 1995-10-30 1996-10-30 歯周病の診断および治療
ZA969130A ZA969130B (en) 1995-10-30 1996-10-30 Diagnostics and treatments of periodontal disease
NZ320015A NZ320015A (en) 1995-10-30 1996-10-30 Purified antigenic complex for raising antibody response against porphyromonas gingivalis
ES96934198T ES2255082T3 (es) 1995-10-30 1996-10-30 Diagnostico y tratamiento de la enfermedad periodontal.
EP96934198A EP0858504B1 (en) 1995-10-30 1996-10-30 Diagnostics and treatments of periodontal disease
KR1019980703117A KR100286055B1 (ko) 1995-10-30 1996-10-30 치주 질환의 진단 및 치료법
US09/066,330 US6511666B1 (en) 1995-10-30 1996-10-30 Diagnostics and treatments of periodontal disease
AT96934198T ATE312909T1 (de) 1995-10-30 1996-10-30 Diagnostika und behandlungen von peridontalen erkrankungen
AU72673/96A AU715456B2 (en) 1995-10-30 1996-10-30 Diagnostics and treatments of periodontal disease
CA2235224A CA2235224C (en) 1995-10-30 1996-10-30 Diagnostics and treatments of periodontal disease
DE69635582T DE69635582T2 (de) 1995-10-30 1996-10-30 Diagnostika und behandlungen von peridontalen erkrankungen
US11/654,512 US20070189982A1 (en) 1995-10-30 2007-01-18 Diagnostics and treatments of Periodontal disease
US13/064,286 US20110213129A1 (en) 1995-10-30 2011-03-16 Diagnostics and treatments of periodontal disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN6275A AUPN627595A0 (en) 1995-10-30 1995-10-30 Diagnostics and treatments of periodontal disease

Publications (1)

Publication Number Publication Date
AUPN627595A0 true AUPN627595A0 (en) 1995-11-23

Family

ID=3790602

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPN6275A Abandoned AUPN627595A0 (en) 1995-10-30 1995-10-30 Diagnostics and treatments of periodontal disease
AU72673/96A Ceased AU715456B2 (en) 1995-10-30 1996-10-30 Diagnostics and treatments of periodontal disease

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU72673/96A Ceased AU715456B2 (en) 1995-10-30 1996-10-30 Diagnostics and treatments of periodontal disease

Country Status (13)

Country Link
US (3) US6511666B1 (https=)
EP (1) EP0858504B1 (https=)
JP (1) JP4117026B2 (https=)
KR (1) KR100286055B1 (https=)
AT (1) ATE312909T1 (https=)
AU (2) AUPN627595A0 (https=)
CA (1) CA2235224C (https=)
DE (1) DE69635582T2 (https=)
DK (1) DK0858504T3 (https=)
ES (1) ES2255082T3 (https=)
NZ (1) NZ320015A (https=)
WO (1) WO1997016542A1 (https=)
ZA (1) ZA969130B (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0735293U (ja) * 1993-12-10 1995-06-27 株式会社松島製作所 もやいの照明装置
US20030157637A1 (en) * 1998-09-15 2003-08-21 The University Of Melbourne Diagnostics and treatments of periodontal disease
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
AUPO652897A0 (en) * 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis
US8129500B2 (en) * 1997-12-10 2012-03-06 Csl Limited Porphyromonas gingivalis polypeptides and nucleotides
ES2377751T3 (es) * 1997-12-10 2012-03-30 Csl Limited Polipéptidos y polinucleótidos de Porfiromonas gingivalis
AUPP494798A0 (en) 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
AUPP893999A0 (en) * 1999-03-01 1999-03-25 Csl Limited Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis
AUPQ485999A0 (en) * 1999-12-24 2000-02-03 Csl Limited P. gingivalis antigenic composition
AUPQ718200A0 (en) 2000-04-28 2000-05-25 Csl Limited Porphyromonas gingivalis recombinant proteins and truncations
SE0400191D0 (sv) * 2004-01-30 2004-01-30 Tendera Ab A test kit for detecting periodontal disease
EP1799705A4 (en) * 2004-09-23 2008-11-05 Univ Melbourne Antigenic complex for the diagnosis and treatment of porphyromonas gingivalis infection
AU2005287884B2 (en) * 2004-09-23 2010-12-02 The University Of Melbourne Antigenic complex for the diagnosis and treatment of Porphyromonas gingivalis infection
AU2007204730B2 (en) 2006-01-10 2011-11-17 Colgate-Palmolive Company Methods of modulating cell surface receptors to prevent or reduce inflammation
CA2652957A1 (en) 2006-06-27 2008-01-03 Oral Health Australia Pty Ltd. Porphyromonas gingivalis polypeptides useful in the prevention of periodontal disease
US20100297179A1 (en) 2007-07-12 2010-11-25 Stuart Geoffrey Dashper Immunology Treatment for Biofilms
WO2009006699A1 (en) 2007-07-12 2009-01-15 Oral Health Australia Pty Ltd Biofilm treatment
DK2328914T3 (en) * 2008-08-29 2017-07-10 Oral Health Australia Pty Ltd Prevention, treatment and diagnosis of P. gingivalis infection
US8140041B2 (en) * 2009-08-27 2012-03-20 Mediatek Inc. Tunable capacitive device with linearization technique employed therein
MY162557A (en) 2010-02-26 2017-06-15 Oral Health Australia Pty Ltd Treatment or prevention of infection
SG11202003147XA (en) 2017-10-12 2020-05-28 Vaxcyte Inc Periodontitis vaccine and related compositions and method of use
CN111172177B (zh) 2019-07-30 2023-08-08 镇江市江澜绿洲生物技术有限公司 cra4S1基因及其编码的蛋白和应用
US10973908B1 (en) 2020-05-14 2021-04-13 David Gordon Bermudes Expression of SARS-CoV-2 spike protein receptor binding domain in attenuated salmonella as a vaccine
US12537071B1 (en) 2020-07-22 2026-01-27 David Gordon Bermudes Bacteria having boolean control pathways expressing therapeutic proteins including immunotherapeutic cytotoxins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5830710A (en) 1988-09-08 1998-11-03 University Of Florida Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease
WO1995000110A1 (en) * 1993-06-28 1995-01-05 Lion Corporation Composition for oral cavity
US5523390A (en) * 1993-09-10 1996-06-04 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase
WO1995007286A1 (en) 1993-09-10 1995-03-16 University Of Georgia Research Foundation, Inc. Porphyromonas gingivalis arginine-specific proteinase coding sequences
US5475097A (en) 1993-10-21 1995-12-12 University Of Georgia Research Foundation, Inc. Lysine-specific Porphyromonas gingivalis proteinase
AUPN627595A0 (en) * 1995-10-30 1995-11-23 University Of Melbourne, The Diagnostics and treatments of periodontal disease
AUPO652897A0 (en) * 1997-04-30 1997-05-29 University Of Melbourne, The Synthetic peptide constructs for the diagnosis and treatment of periodontitis

Also Published As

Publication number Publication date
EP0858504A1 (en) 1998-08-19
AU7267396A (en) 1997-05-22
JP2000510817A (ja) 2000-08-22
NZ320015A (en) 1999-02-25
ATE312909T1 (de) 2005-12-15
US20070189982A1 (en) 2007-08-16
KR100286055B1 (ko) 2001-05-02
US6511666B1 (en) 2003-01-28
KR19990067167A (ko) 1999-08-16
JP4117026B2 (ja) 2008-07-09
DK0858504T3 (da) 2006-02-13
CA2235224C (en) 2011-11-29
CA2235224A1 (en) 1997-05-09
EP0858504B1 (en) 2005-12-14
AU715456B2 (en) 2000-02-03
US20110213129A1 (en) 2011-09-01
ZA969130B (en) 1997-06-24
EP0858504A4 (en) 2002-12-04
ES2255082T3 (es) 2006-06-16
WO1997016542A1 (en) 1997-05-09
DE69635582T2 (de) 2006-08-17
DE69635582D1 (de) 2006-01-19

Similar Documents

Publication Publication Date Title
AUPN627595A0 (en) Diagnostics and treatments of periodontal disease
ATE257390T1 (de) Verwendung eines bpi proteinproduktes als antithrombotisches mittel
CY1110128T1 (el) Καταλυτικα μονοκλωνικα αντισωματα με δραστικοτητα πρωτεασης για την εκλεκτικη λυση του πρωτεϊνικου συστατικου των πλακων και συνονθυλευματων που σχετιζονται με παθολογικες καταστασεις
HUP9802212A2 (hu) Humán terápiában alkalmazható rekombináns anti-CD4-ellenanyagok
AU3909497A (en) Anti-chlamydial methods and materials
DE69526216D1 (de) Antifungaleverfahren und mitteln
PT865294E (pt) Processo para a reducao ou a manutencao de niveis reduzidos de lipidos no sangue utilizando composicoes de proteina ob
DE69410254D1 (de) Behandlung von mycobakteriellen erkrankungen durch verabreichung von bakrerientötende, durchlässigkeitserhöhende proteinfragmente
EP0584343A4 (en) Recombinant calf intestinal alkaline phosphatase
AU2967595A (en) Anti-protozoan methods and materials
NO974322L (no) DNA som koder for human papillomvirus type 18
ES2052893T3 (es) Preparado de n-acetil-glucosamina para administracion por via bucal.
SG48816A1 (en) Gonococcal anti-idiotypic antibodies and methods and compositions using them
AU7970894A (en) Method of treating depressed reticuloendothelial system function
BR9405606A (pt) Uso de amidoaminas em composições oftálmicas
CA2137280A1 (fr) Clonage du gene codant pour la proteine gp28.5 de toxoplasma gondii; fragments peptidiques de cette proteine et leurs applications
GB9501826D0 (en) Polypeptide fragments
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
AU1041397A (en) Antigenic protein originating in malassezia
BR9611904A (pt) Dioxidos de ditiazol
EA199600048A2 (ru) N,n-диэтил-8,8-дипропил-2-азаспиро[4,5]декан-2-пропанамин дималеат, фармацевтическая композиция на его основе и способ индуцирования иммуномодуляции
DE59611353D1 (de) Transketolase-verwandtes protein
ES2191785T3 (es) Proteina de accion antitumoral.
IT8882546A0 (it) Impianto per il trattamento superficiale e l'eventuale accumulo dei prodotti, in particolare diprodotti in legno come serramenti, infissi e simili.